Relative Study on Patent Output and Economic Output in Heilongjiang Pharmaceutical Enterprises

LU Lu; YANG Jun; PAN Yan-juan; CHEN Feng; YAN Xi-qing; QIU Pei-yong; ZHANG Jing; LU Guang-zhou; YAN Fu-lin

您当前的位置：

首页 >

文章列表页 >

Relative Study on Patent Output and Economic Output in Heilongjiang Pharmaceutical Enterprises

更新时间：2024-01-04

- Relative Study on Patent Output and Economic Output in Heilongjiang Pharmaceutical Enterprises
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 5, Pages: 256-262(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012
- 稿件说明：
移动端阅览
LU Lu, YANG Jun, PAN Yan-juan, et al. Relative Study on Patent Output and Economic Output in Heilongjiang Pharmaceutical Enterprises[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(5): 256-262.
DOI：

LU Lu, YANG Jun, PAN Yan-juan, et al. Relative Study on Patent Output and Economic Output in Heilongjiang Pharmaceutical Enterprises[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(5): 256-262. DOI：

摘要

研究黑龙江省生物医药企业专利保护现状

并分析了黑龙江省上市生物医药企业专利申请量与其经济效益的相关性。分析了黑龙江省49家医药企业的专利申请情况

运用相关回归方法分析了3家上市医药企业1999-2010年专利申请数与经济产出(年销售收入/净利润)的相关性。结果显示上市医药企业专利产出与经济收入成正相关

回归方程有良好的线性关系

方差分析具显著性效果;黑龙江省49家生物医药企业中19家企业(占38.8%)专利申请量为零

24家企业(占49.0%)专利申请量不超过10件。虽然黑龙江省部分生物医药企业在专利保护上作了工作

但是大部分生物医药企业对专利保护重视不足

企业增加创新投入同时

一定要注重专利保护。

Abstract

Pharmaceutical companies in Heilongjiang Province and its associated economic benefits

Analysis of intellectual property protection.Using the relevant regression method

the present study analyzed the relationships between the patent output and the economic output in the three listed pharmaceutical enterprises from 1999 to 2010

and the patent status of the main 49 pharmaceutical enterprises in Heilongjiang Province. The two listed pharmaceutical companies patent output was positively correlated with there incomes

which had a good linear regression relationship between the analysis of variance with significant effects. There were 19 pharmaceutical enterprises without a patent application in the 49 pharmaceutical enterprises. 24 pharmaceutical enterprises have no more than 10 pieces of patent application. Two listed pharmaceutical companies in Heilongjiang Province in remarkable effectiveness of patent protection

but there are still some companies do not realize the importance of patent protection. So it still needs to strengthen patent protection measures to raise awareness of pharmaceutical patent protection.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Correlation between Patent Output and Economic Output for Well-known Chinese Medicine Enterprises

Analyzing Progress and Achievements in Innovative Research of Traditional Chinese Medicine in Past Three Decades from Patent Perspective

Research of Anticancer Realgar Preparations from Perspective of Patent

Overview of Research on Chinese Medicine Patents for Prevention and Treatment of Asthenopia and Analysis Their Medication Rule

Related Author

WANG Jing-cheng

WANG Da-xin

YANG Jun

LU Guang-zhou 1

WANG Da-xin3

YAN Fu-lin1

ZHANG Jing 2

YANG Jun1

Related Institution

Xinxiang Medical University

Hunan KAMP Institute for Medical Research

Jiangsu Subei People’s Hospital

KAMP Pharmacy Co.Ltd.

Department of Pharmaceutical and Biological Invention Examination，Patent Office， China National Intellectual Property Administration

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰